NCT02936895

Vitamin D Supplementation and Respiratory Index of Severity in Children (RISC) in Pneumonia

The Effects of Vitamin D Supplementation in Respiratory Index of Severity in Children (RISC) of Hospitalized Patients With Community-acquired Pneumonia

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 100 (actual)
• Sponsor: Hormozgan University of Medical Sciences · Academic / Other
• Sex: All
• Age: 2 Months – 6 Years
• Healthy volunteers: Not accepted

Summary

Childhood deaths from pneumonia is almost 2000 times higher in developing countries than in developed countries. In 1970, pneumonia was responsible for 9% of all deaths in children under 5 years. This rate was 2% in 2007. Some studies have shown that supplementing with vitamin D reduces disease of the respiratory tract infection. Some other studies have shown anti-inflammatory effect of vitamin D in cell lines. Studies about the role of vitamin D supplementation in pneumonia in children are inadequate to conclude about its role. The aim of this study is to determine the efficacy of vitamin D supplementation in Respiratory Index of Severity in Children (RISC) hospitalized clinical outcomes of hospitalized patients with community-acquired pneumonia.

Conditions

• Pneumonia

Interventions

Type	Name	Description
DRUG	Vitamin D3	vitamin D at a dose of 50,000 IU per day for 2 days
DRUG	Placebo	Placebo for 2 days

Timeline

• Start date: 2015-01-01
• Primary completion: 2016-01-01
• Completion: 2016-09-01
• First posted: 2016-10-18
• Last updated: 2016-10-18

Locations

1 site across 1 country: Iran